On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

EVIO, Inc. (EVIO) Puts Cannabis Quality and Safety to the Test

    • EVIO lab test revenues related to cannabis products grew by 782 percent last year
    • Cannabis testing weeds out impurities such as chemicals and fungi while also analyzing potency
    • Amid news of acclaimed accreditation in Florida, company plans major nationwide expansion

    As the cannabis industry continues to quietly flourish in North America, EVIO, Inc. (OTCQB: EVIO) is providing laboratory testing to help consumers ensure that the plant products they are getting meet stringent standards of healthful quality. The company has gained renown for its services as it provides consulting and high-quality analysis of cannabis plants grown under state-legal programs throughout the United States for food retail, recreational smoking and biomedical purposes.

    The company plans to reach a total of 18 laboratories in the United States by the end of the year. In the meantime, clients can bring plant samples into the Oregon-based company’s labs in Colorado or four other states along the East and West Coasts or ask a lab representative to make an on-site visit for random sampling. The lab will visually inspect the plants for signs of mold or foreign matter and analyze the water, microbiological and chemical content to detect bacteria, fungi, solvents and other potential contaminants.

    The laboratory analysis not only aims to ensure the purity of the grower’s cannabis product, but the potency as well. A Great Britain study that highlighted the dangers of unregulated marijuana commerce in that country found that almost all cannabis seized during the investigation of illegal activity is of a high-strength variety designed to increase its psychoactive qualities. The study found that the amount of high-potency ‘skunk’ in the drug seizures had increased from 51 percent in 2005 to 94 percent in 2016 in five key regions across the country. The researchers claim that an increasing discrepancy between psychoactive THC and non-psychoactive CBD levels in cannabis could increase the number of users at risk of developing psychotic disorders – a view supported by a number of academics not involved in the research, according to The Guardian (http://ibn.fm/xZUM4).

    “This is actually worrying because if we do believe that there are types of cannabis that can be used more safely – because of the presence of cannabidiol – well, at least in this country, these are disappearing,” Dr. Marta Di Forti, one of the authors from King’s College London, stated in the research.

    A special report published in The Journal of the American Osteopathic Association in February (http://ibn.fm/WqTcH) echoes the concerns among North American consumers, stating that the higher potency drugs pose mental health risks to some patients, such as schizophrenia and other psychiatric issues, and that health care providers, particularly pediatricians, “should be aware of this, especially for patients who have exhibited symptoms of anxiety and depression, and be willing to have candid discussions about cannabis.”

    EVIO’s dedication to ensuring the quality and potency of cannabis products “is a key element of the company’s success and one that should matter most to cannabis consumers, who are often seeking relief from specific ailments. In fact, EVIO Labs Florida recently achieved ISO 17025 accreditation, becoming the first accredited cannabis testing lab in the state,” a recent article about the company states (http://ibn.fm/pcIFB). “This achievement, which marks the highest recognized quality standard in the world for calibration and testing laboratories, means that EVIO Labs Florida consistently produces precise and accurate tests that are implemented under a rigorous quality management system.”

    The company’s end of fiscal year statement for 2017’s third quarter reports that testing revenues had grown from $305,679 the previous year to nearly $2.7 million, marking a 782 percent jump, with its consulting services providing a more modest revenue increase to $324,803. Once the expenses of testing and consulting were factored in, EVIO’s gross profit grew from $33,906 in 2016 to $564,507 last year.

    The company received a vote of confidence from investors willing to put their money where their heart is when EVIO closed a nearly $6 million private placement that practically doubled the initial $3 million target (http://ibn.fm/eWrp5) earlier this year. EVIO, Inc. has more accredited cannabis testing laboratories in operation than any other company in the industry, and the planned additions aims to ensure its foothold.

    For more information, visit the company’s website at www.EVIOLabs.com

    About QualityStocks

    QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

    QualityStocks (QS)
    Scottsdale, Arizona
    www.QualityStocks.com
    480.374.1336 Office
    [email protected]

    Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

     

Archives

Select A Month
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Market Basics

    New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

    The Basics

    Newsletter Publishers

    Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

    Register

    Public Companies

    Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

    Get Covered